These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 3400265

  • 1. Incidence of a subclinical fascioliasis on antipyrine clearance and metabolite excretion in sheep.
    Tufenkji AE, Alvinerie M, Pineau T, Boulard C, Galtier P.
    Xenobiotica; 1988 Apr; 18(4):357-64. PubMed ID: 3400265
    [Abstract] [Full Text] [Related]

  • 2. Decrease in albendazole sulphonation during experimental fascioliasis in sheep.
    Galtier P, Alvinerie M, Plusquellec Y, Tufenkji AE, Houin G.
    Xenobiotica; 1991 Jul; 21(7):917-24. PubMed ID: 1776267
    [Abstract] [Full Text] [Related]

  • 3. Incidence of experimental fascioliasis on the activity of drug-metabolizing enzymes in lamb liver.
    Galtier P, Larrieu G, Tufenkji AE, Franc M.
    Drug Metab Dispos; 1986 Jul; 14(1):137-41. PubMed ID: 2868858
    [Abstract] [Full Text] [Related]

  • 4. Antipyrine as a probe for human oxidative drug metabolism: identification of the cytochrome P450 enzymes catalyzing 4-hydroxyantipyrine, 3-hydroxymethylantipyrine, and norantipyrine formation.
    Engel G, Hofmann U, Heidemann H, Cosme J, Eichelbaum M.
    Clin Pharmacol Ther; 1996 Jun; 59(6):613-23. PubMed ID: 8681486
    [Abstract] [Full Text] [Related]

  • 5. Pharmacokinetics of sulphobromophthalein, lidocaine and indocyanine green in the course of subclinical fascioliasis in sheep.
    Tufenkji AE, Alvinerie M, Houin G, Galtier P.
    Res Vet Sci; 1987 Nov; 43(3):327-30. PubMed ID: 3444979
    [Abstract] [Full Text] [Related]

  • 6. Comparative incidence of experimental fascioliasis on corticosteroid pharmacokinetics in sheep.
    Alvinerie M, Tufenkji AE, Houin G, Toutain PL, Galtier P.
    Comp Biochem Physiol C Comp Pharmacol Toxicol; 1989 Nov; 94(1):81-6. PubMed ID: 2576748
    [Abstract] [Full Text] [Related]

  • 7. Effect of experimental fasciolosis on antipyrine metabolism and clearance in water buffaloes.
    Jiang SX, Bayón JE, Ferre I, Mao XZ, González-Gallego J.
    Vet Parasitol; 2000 Mar 01; 88(3-4):177-86. PubMed ID: 10714456
    [Abstract] [Full Text] [Related]

  • 8. Pharmacological basis for hepatic drug metabolism in sheep.
    Galtier P, Alvinerie M.
    Vet Res; 1996 Mar 01; 27(4-5):363-72. PubMed ID: 8822607
    [Abstract] [Full Text] [Related]

  • 9. Experimental ovine fasciolosis: antipyrine clearance as indicator of liver damage.
    Ferre I, López P, Rojo-Vázquez FA, González-Gallego J.
    Vet Parasitol; 1996 Mar 01; 62(1-2):93-100. PubMed ID: 8638398
    [Abstract] [Full Text] [Related]

  • 10. The effect of age on antipyrine pharmacokinetics and metabolite formation in rats.
    van Bezooijen CF, van Oorschot RM.
    J Pharmacol Exp Ther; 1989 Nov 01; 251(2):683-6. PubMed ID: 2810117
    [Abstract] [Full Text] [Related]

  • 11. Induction of hexobarbital and antipyrine metabolism by rifampicin treatment in the pig.
    van den Broek JM, Teunissen MW, Breimer DD.
    Drug Metab Dispos; 1981 Nov 01; 9(6):541-4. PubMed ID: 6120813
    [Abstract] [Full Text] [Related]

  • 12. Antipyrine pharmacokinetics and urinary excretion in female horses.
    Dyke TM, Sams RA, Hinchcliff KW.
    Am J Vet Res; 1998 Mar 01; 59(3):280-5. PubMed ID: 9522945
    [Abstract] [Full Text] [Related]

  • 13. Effect of early treatment with rafoxanide on antipyrine clearance in sheep infected with Fasciola hepatica.
    Benchaoui HA, McKellar QA.
    Xenobiotica; 1993 Apr 01; 23(4):439-48. PubMed ID: 8101676
    [Abstract] [Full Text] [Related]

  • 14. Effect of fusidic acid on the hepatic cytochrome P450 enzyme system.
    Reimann G, Barthel B, Rockstroh JK, Spatz D, Brockmeyer NH.
    Int J Clin Pharmacol Ther; 1999 Nov 01; 37(11):562-6. PubMed ID: 10584978
    [Abstract] [Full Text] [Related]

  • 15. The effect of experimental fascioliasis on the pharmacokinetics of antipyrine and sulphadimidine in desert sheep.
    Elsheikh HA, Ali BH.
    J Vet Pharmacol Ther; 1997 Jun 01; 20(3):167-72. PubMed ID: 9185081
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Fasciola hepatica: mebendazole and thiabendazole pharmacokinetics in sheep.
    Galtier P, Coulet M, Sutra JF, Biro-Sauveur B, Alvinerie M.
    Exp Parasitol; 1994 Sep 01; 79(2):166-76. PubMed ID: 7914496
    [Abstract] [Full Text] [Related]

  • 18. Impact of amphotericin B on the cytochrome P450 system in HIV-infected patients.
    Brockmeyer NH, Gambichler T, Bader A, Kreuter A, Kurowski M, Sander P, Altmeyer P.
    Eur J Med Res; 2004 Feb 27; 9(2):51-4. PubMed ID: 15090289
    [Abstract] [Full Text] [Related]

  • 19. Host responses during experimental infection with Fasciola gigantica or Fasciola hepatica in Merino sheep I. Comparative immunological and plasma biochemical changes during early infection.
    Raadsma HW, Kingsford NM, Suharyanta, Spithill TW, Piedrafita D.
    Vet Parasitol; 2007 Feb 28; 143(3-4):275-86. PubMed ID: 17069976
    [Abstract] [Full Text] [Related]

  • 20. Correlation between antipyrine metabolite formation and theophylline metabolism in humans after simultaneous single-dose administration and at steady state.
    Teunissen MW, De Leede LG, Boeijinga JK, Breimer DD.
    J Pharmacol Exp Ther; 1985 Jun 28; 233(3):770-5. PubMed ID: 4009489
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.